Cantargia AB (publ) (STO:CANTA)
3.800
-0.130 (-3.31%)
Apr 29, 2026, 11:50 AM CET
Cantargia AB Revenue
In the year 2025, Cantargia AB had annual revenue of 316.70M SEK. Cantargia AB had revenue of 8.01M in the quarter ending December 31, 2025.
Revenue
316.70M
Revenue Growth
n/a
P/S Ratio
3.09
Revenue / Employee
14.40M
Employees
22
Market Cap
977.04M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medivir AB | 8.51M |
| Xspray Pharma AB | 2.47M |
| Infant Bacterial Therapeutics AB | -1.00K |
| FluoGuide | 318.79K |
| Genovis AB (publ.) | 129.65M |
| BioInvent International AB | 226.50M |
| Oncopeptides AB | 71.12M |
| Saniona AB | 434.40M |
Cantargia AB News
- 2 months ago - Cantargia AB (FRA:7V3) Q4 2025 Earnings Call Highlights: A Year of First-Time Profitability ... - GuruFocus
- 2 months ago - Q4 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 2 months ago - Cantargia AB Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Cantargia AB (FRA:7V3) Q3 2025 Earnings Call Highlights: First-Ever Profits and Promising ... - GuruFocus
- 5 months ago - Q3 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 5 months ago - Cantargia AB Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Cantargia AB Transcript: Life Science Summit 2025 - Transcripts
- 7 months ago - Cantargia AB Transcript: Investing in Life Science 2025 - Transcripts